Results 31 to 40 of about 48,810 (253)

Malignant pericardial mesothelioma [PDF]

European Journal of Cardio-Thoracic Surgery, 2011
A 72-year-old female, who had no asbestos exposure, felt chest pain. She was diagnosed with pericarditis. After 6 months, a follow-up chest computed tomography (CT) showed a thickened pericardium (Fig. 1(A) and (B)) and a positron emission tomography (PET) scan was positive along the pericardium (Fig. 1(C)).
Motoki, Sakuraba, Takahiro, Tatsumori, Michihiro, Hirama, Kanako, Ogura   +3 more
openaire   +2 more sources

Late cutaneous metastases to the face from malignant pleural mesothelioma: A case report and review of the literature

World Journal of Surgical Oncology, 2009
Background Malignant Mesothelioma is a rare primary neoplasm affecting the serosal membranes. During its relative short course, this malignant neoplasm can give local and, rarely, distant haematogenous metastases in different organs.
Lawrence Julia, Kamel Dia E, Elbahaie Alaaeldeen M, Davidson Neville G   +3 more
doaj   +1 more source

Pleuropericardial mesotheliomas: A report of two unusual cases

Asian Journal of Oncology, 2018
Mesothelioma is an aggressive malignant tumor of the mesothelium. The majority of mesotheliomas arise from the pleura. However, less commonly mesothelioma can arise in other locations such as peritoneal, pericardium, or tunica vaginalis testis. We report
Harsha Vardhana Kuruba Ramanjaneyulu, Anu Kapoor, Chinmayee Biswal, Phani Chakravrty Mutnuru   +3 more
doaj   +1 more source

Communicating imaging findings in peritoneal mesothelioma: the impact of ‘PAUSE’ on surgical decision-making

Insights into Imaging, 2021
The peritoneal cavity is the second commonest site of mesothelioma after the pleural cavity. There are five histological types of peritoneal mesothelioma with variable symptomatology, clinical presentation and prognosis.
Anuradha Chandramohan, Nehal Shah, Andrew Thrower, Norman John Carr, Rohin Mittal, Faheez Mohamed, Brendan Moran   +6 more
doaj   +1 more source

Massive Pleural Effusion Leads to the Revelation of Malignant Pleural Mesothelioma: A Case Report

Jurnal Respirasi
Introduction: Malignant mesothelioma is a cancer that develops from the thin layer of tissue covering visceral organs (mesothelium). Up to 80% of malignant mesothelioma cases are caused by asbestos exposure.
Gede Adi Prasetya Wijaya, Ivan Leonard Winardy Oei, Wayan Wahyu Semara Putra, Novitasari Novitasari   +3 more
doaj   +1 more source

Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment

European Respiratory Review, 2016
Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface, predominantly caused by prior asbestos exposure. There is a global epidemic of malignant pleural mesothelioma underway, and incidence rates are predicted to peak in the ...
Anna C. Bibby, Selina Tsim, Nikolaos Kanellakis, Hannah Ball, Denis C. Talbot, Kevin G. Blyth, Nick A. Maskell, Ioannis Psallidas   +7 more
doaj   +1 more source

Malignant pleural mesothelioma

Annals of Oncology, 2006
Malignant pleural mesothelioma G. L. Ceresoli, G. P. Betta, B. Castagneto, F. Facciolo, G. Arcangeli, P. A. Zucali, R. Libener, D. De Giovanni, E. Melis & M. A. Mirri Department of Medical Oncology and Hematology, Istituto Clinico Humanitas IRCCS, Rozzano (MI); Pathology Unit, Department of Oncology, Azienda Sanitaria Ospedaliera, Alessandria ...
G L, Ceresoli, G P, Betta, B, Castagneto, F, Facciolo, G, Arcangeli, P A, Zucali, R, Libener, D, De Giovanni, E, Melis, M A, Mirri   +9 more
openaire   +2 more sources

Management of Malignant Pleural Mesothelioma

, 2019
Malignant mesothelioma (MM) arises from mesothelial surfaces of the pleural cavity, peritoneal cavity, tunica vaginalis, or pericardium. MM is a rare and insidious neoplasm with a poor prognosis.
Güngör Utkan, Mustafa Gürbüz
core   +1 more source

Malignant Mesothelioma Diagnosis

Archives of Pathology & Laboratory Medicine, 2015
Malignant mesothelioma is a relatively rare pleural tumor that may mimic benign mesothelial lesions and various other tumors including carcinomas and sarcomas. This makes the diagnosis challenging for the pathologist.To provide a brief but useful update on the immunohistochemical, cytogenetic, and molecular markers that are currently available for the ...
Qudsia, Arif, Aliya N, Husain
openaire   +2 more sources

From energy provision to protein synthesis: Tunnelling nanotubes as mediators of intercellular metabolic cooperation in cancer

FEBS Open Bio, EarlyView.
The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley   +1 more source